The Effects of Aerobic Exercise on N-terminal Pro-B-type Natriuretic Peptide and Cardiopulmonary Function in Patients With Heart Failure: A Meta-Analysis of Randomised Clinical Trials

Background Aerobic exercise (AEx) improves outcomes in heart failure (HF). N-terminal pro B-type natriuretic peptide
(NT-pro-BNP) is a prognosticator in HF. There are few data on the association of AEx, NT-pro-BNP, and
cardiopulmonary function; hence, robust evidence is needed. The aim of this study was to measure the
effects of AEx on NT-pro-BNP levels and cardiopulmonary function in HF.
Method Databases (Pubmed, EMBASE, Medline, Cochrane Central Registry, and Scopus) were systematically
searched for randomised controlled trials (RCTs) that assessed the association of AEx with NT-pro-BNP
and cardiopulmonary function (VE/VCO2 slope, peak VO2, maximal workload, and left ventricular ejection
fraction [LVEF]) in HF. RevMan 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration,
Copenhagen, 2014) was used to produce forest plots, and the random-effect model was applied with the
effects measure of weighted mean differences (WMD) and 95% confidence interval (CI).
Results Thirteen (13) RCTs recruited 1,503 patients and 1,494 controls. Aerobic exercise was significant in lowering
NT-pro-BNP (pg/mL) compared with control group (WMD=2741.69, 95% CI 2993.10 to 2490.27
[p,0.00001; I2=63%]). VE/VCO2 slope was also significantly reduced (WMD=23.57, 95% CI 26.48
to 20.67 [p=0.02; I2=97%]). Peak VO2 (mL/kg/min) significantly improved (WMD=3.68, 95% CI 2.39–4.96
[p,0.00001; I2=96%]). Maximal workload (watt) significantly increased following AEx (WMD=22.80, 95%
CI 18.44–27.17 [p,0.00001; I2=78%]). Furthermore, there was a significant enhancement of LVEF (%) in the
AEx group (WMD=2.42, 95% CI 0.64–4.19 [p=0.008; I2=71%]).
Conclusions Aerobic exercise improves the NT-pro-BNP, ventilatory efficiency, aerobic capacity, maximal workload,
and the left ventricular function in patients with HF.